Gray Market GLP-1 Is Booming Branded Access is Broken
From On The Pen GLP-1 News · · 26 min
This plays from the publisher's own server. We do not host a copy.
Description
Send a text (https://www.buzzsprout.com/twilio/text_messages/2302090/open_sms)
Episode Summary (Short Version):
This week on On The Pen, Dave breaks down the rapid changes reshaping GLP-1 access — from new federal reforms targeting PBMs and possible FDA limits on compounded semaglutide, to Walgreens and Amazon launching cash-pay weight loss clinics.
As insurance denials continue and out-of-pocket costs rise, patients are stuck between a shifting policy landscape and a growing direct-to-consumer market. Plus, an AI-designed oral GLP-1 enters Phase 3 trials, signaling how fast obesity medicine is evolving.
Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!
🤝 Visit Our Sponsors! OTPLinks.com
Decoding GLP-1 Book Decoding GLP-1: A Guide for Friends and Family of Those On The Pen Buy Here: https://amzn.to/3Dc66d4
MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT: Venmo: OnThePen Ca$h App: ManOnMounjaro
BECOME A MEMBER: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
👉 My Amazon Affiliate Store: https://www.amazon.com/shop/manonthemounjaroonthepen
WATCH MORE! 📺 We're Live M/W/F at 11 central: onthepen.tv (http://www.onthepen.tv)
📲 Contact Me: dave@onthepen.com
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepen.com.